Axogen to buy BioCircuit Technologies for $200M in cash
Axogen, NASDAQ:AXGN, has agreed to acquire privately held medical-device company BioCircuit Technologies for $200M in cash. The company plans to fund the purchase price with net proceeds from a concurrent public offer.
Axogen NASDAQ:AXGN has agreed to acquire privately held medical-device company BioCircuit Technologies for $200M in cash. The deal is intended to expand Axogen’s portfolio of surgical solutions for peripheral nerve repair. Axogen said it expects to fund the purchase price with the net proceeds from a concurrent public offering.